Study of the use of Ramipril in patients at risk with Covid-19. Analysis from the Rastavi Clinical Trial
- Funded by Junta de Castilla y Leon - Consejeria de Sanidad
- Total publications:0 publications
Grant number: GRS COVID 115/A/20
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$7,927.56Funder
Junta de Castilla y Leon - Consejeria de SanidadPrincipal Investigator
Sandra Santos MartínezResearch Location
SpainLead Research Institution
Hospital Clínico Universitario De ValladolidResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Clinical trials for disease management
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified